Darin Lippoldt insider trades: Neurocrine Biosciences (NBIX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Darin reports to the SEC
Open-market buys and sales
61 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | NBIX | ↓ Sell | 10,000 | $170.15 | $1.7M | Direct | Jun 30, 2026 (1d) |
| Dec 8, 2025 | NBIX | ↓ Sell | 4,376 | $159.65 | $699K | Direct | Dec 10, 2025 (2d) |
| Feb 13, 2025 | NBIX | ↓ Sell | 2,184 | $116.75 | $255K | Direct | Feb 14, 2025 (1d) |
| Feb 10, 2025 | NBIX | ↓ Sell | 911 | $118.25 | $108K | Direct | Feb 12, 2025 (2d) |
| Jan 31, 2025 | NBIX | ↓ Sell | 1,250 | $152.91 | $191K | Direct | Feb 4, 2025 (4d) |
| Aug 1, 2024 | NBIX | ↓ Sell | 2,996 | $154.01 | $461K | Direct | Aug 5, 2024 (4d) |
| Jul 16, 2024 | NBIX | ↓ Sell | 7,004 | $150.00 | $1.1M | Direct | Jul 18, 2024 (2d) |
| Feb 13, 2024 | NBIX | ↓ Sell | 1,098 | $132.99 | $146K | Direct | Feb 15, 2024 (2d) |
| Feb 8, 2024 | NBIX | ↓ Sell | 1,952 | $138.47 | $270K | Direct | Feb 8, 2024 (0d) |
| Jan 31, 2024 | NBIX | ↓ Sell | 1,250 | $140.65 | $176K | Direct | Feb 2, 2024 (2d) |
| Jan 22, 2024 | NBIX | ↓ Sell | 10,000 | $139.86 | $1.4M | Direct | Jan 24, 2024 (2d) |
| Dec 6, 2023 | NBIX | ↓ Sell | 20,830 | $119.86 | $2.5M | Direct | Dec 8, 2023 (2d) |
| Nov 27, 2023 | NBIX | ↓ Sell | 10,919 | $112.27 | $1.2M | Direct | Nov 29, 2023 (2d) |
| Aug 21, 2023 | NBIX | ↓ Sell | 2,132 | $107.39 | $229K | Direct | Aug 23, 2023 (2d) |
| Feb 8, 2023 | NBIX | ↓ Sell | 16,275 | $102.71 | $1.7M | Direct | Feb 8, 2023 (0d) |
| Jan 31, 2023 | NBIX | ↓ Sell | 1,250 | $109.97 | $137K | Direct | Feb 2, 2023 (2d) |
| Nov 8, 2022 | NBIX | ↓ Sell | 5,082 | $125.04 | $635K | Direct | Nov 10, 2022 (2d) |
| Nov 3, 2022 | NBIX | ↓ Sell | 4,518 | $125.02 | $565K | Direct | Nov 4, 2022 (1d) |
| Nov 2, 2022 | NBIX | ↓ Sell | 10,400 | $120.28 | $1.3M | Direct | Nov 2, 2022 (0d) |
| Oct 27, 2022 | NBIX | ↓ Sell | 10,000 | $115.03 | $1.2M | Direct | Oct 28, 2022 (1d) |
| Oct 4, 2022 | NBIX | ↓ Sell | 10,000 | $111.04 | $1.1M | Direct | Oct 5, 2022 (1d) |
| Mar 22, 2022 | NBIX | ↓ Sell | 8,755 | $95.05 | $832K | Direct | Mar 22, 2022 (0d) |
| Feb 8, 2022 | NBIX | ↓ Sell | 4,079 | $80.45 | $328K | Direct | Feb 9, 2022 (1d) |
| Feb 9, 2021 | NBIX | ↓ Sell | 40,206 | $116.19 | $4.7M | Direct | Feb 9, 2021 (0d) |
| Nov 12, 2020 | NBIX | ↓ Sell | 2,257 | $90.72 | $205K | Direct | Nov 16, 2020 (4d) |
| Aug 5, 2020 | NBIX | ↓ Sell | 2,257 | $118.87 | $268K | Direct | Aug 7, 2020 (2d) |
| Jul 9, 2020 | NBIX | ↓ Sell | 1,657 | $136.02 | $225K | Direct | Jul 10, 2020 (1d) |
| Jun 23, 2020 | NBIX | ↓ Sell | 5,000 | $130.00 | $650K | Direct | Jun 25, 2020 (2d) |
| May 18, 2020 | NBIX | ↓ Sell | 5,000 | $120.00 | $600K | Direct | May 20, 2020 (2d) |
| Apr 24, 2020 | NBIX | ↓ Sell | 1,934 | $99.49 | $192K | Direct | Apr 28, 2020 (4d) |
| Feb 7, 2020 | NBIX | ↓ Sell | 1,522 | $103.32 | $157K | Direct | Feb 11, 2020 (4d) |
| Feb 6, 2020 | NBIX | ↓ Sell | 2,948 | $102.36 | $302K | Direct | Feb 7, 2020 (1d) |
| Nov 8, 2019 | NBIX | ↓ Sell | 10,000 | $110.01 | $1.1M | Direct | Nov 13, 2019 (5d) |
| Sep 3, 2019 | NBIX | ↓ Sell | 6,736 | $100.00 | $674K | Direct | Sep 5, 2019 (2d) |
| Aug 27, 2019 | NBIX | ↓ Sell | 3,264 | $100.05 | $327K | Direct | Aug 27, 2019 (0d) |
| Jul 30, 2019 | NBIX | ↓ Sell | 15,831 | $92.13 | $1.5M | Direct | Jul 31, 2019 (1d) |
| Feb 6, 2019 | NBIX | ↓ Sell | 791 | $83.52 | $66K | Direct | Feb 8, 2019 (2d) |
| Feb 5, 2019 | NBIX | ↓ Sell | 1,225 | $88.09 | $108K | Direct | Feb 6, 2019 (1d) |
| Mar 5, 2018 | NBIX | ↓ Sell | 1,979 | $88.47 | $175K | Direct | Mar 7, 2018 (2d) |
| Feb 5, 2018 | NBIX | ↓ Sell | 2,737 | $83.12 | $227K | Direct | Feb 7, 2018 (2d) |
| Jan 3, 2018 | NBIX | ↓ Sell | 1,979 | $79.36 | $157K | Direct | Jan 4, 2018 (1d) |
| Dec 28, 2017 | NBIX | ↓ Sell | 15,237 | $75.00 | $1.1M | Direct | Jan 2, 2018 (5d) |
| Dec 8, 2017 | NBIX | ↓ Sell | 2,955 | $75.00 | $222K | Direct | Dec 11, 2017 (3d) |
| Dec 4, 2017 | NBIX | ↓ Sell | 6,279 | $75.04 | $471K | Direct | Dec 6, 2017 (2d) |
| Nov 15, 2017 | NBIX | ↓ Sell | 9,900 | $73.05 | $723K | Direct | Nov 17, 2017 (2d) |
| Sep 6, 2017 | NBIX | ↓ Sell | 100 | $60.00 | $6K | Direct | Sep 8, 2017 (2d) |
| Aug 9, 2017 | NBIX | ↓ Sell | 5,000 | $55.00 | $275K | Direct | Aug 14, 2017 (5d) |
| May 18, 2017 | NBIX | ↓ Sell | 10,000 | $53.27 | $533K | Direct | May 23, 2017 (5d) |
| Apr 12, 2017 | NBIX | ↓ Sell | 13,065 | $50.42 | $659K | Direct | Apr 13, 2017 (1d) |
| Feb 7, 2017 | NBIX | ↓ Sell | 953 | $43.34 | $41K | Direct | Feb 8, 2017 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NBIX insiders
Open-market trades in the last 12 months
About Darin Lippoldt's insider trades
Darin Lippoldt is Chief Legal Officer at Neurocrine Biosciences (NBIX). Since Feb 16, 2012, Darin has reported no open-market purchases and 61 sales worth $35.1M on SEC Form 4. In the last 12 months: 2 sales ($2.4M).
Their filings also include option exercises (45 filings), grants and awards (19 filings), gifts (5 filings), shares withheld for taxes (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NBIX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.